Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 216 Cr.
- Current Price ₹ 207
- High / Low ₹ 260 / 115
- Stock P/E 22.0
- Book Value ₹ 52.6
- Dividend Yield 0.00 %
- ROCE 44.8 %
- ROE 41.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 54.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.1%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.4.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
51 | 56 | 56 | 60 | 101 | 109 | 106 | |
48 | 53 | 53 | 57 | 95 | 98 | 95 | |
Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 |
OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% |
0 | 0 | 0 | 1 | 2 | 2 | 4 | |
Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 |
Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 |
Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% |
1 | 1 | 0 | 1 | 5 | 8 | 10 | |
EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 413.07 | 9.39 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 21% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 54% |
3 Years: | 93% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 34% |
3 Years: | 41% |
Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 |
Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 |
9 | 11 | 14 | 14 | 10 | 7 | 7 | |
12 | 14 | 23 | 15 | 32 | 34 | 35 | |
Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 |
7 | 8 | 10 | 11 | 12 | 13 | 18 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 1 | 0 | 1 | 0 | 5 |
21 | 25 | 33 | 29 | 42 | 51 | 74 | |
Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 |
Cash Flows
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
0 | 0 | 2 | -4 | 12 | 9 | -8 | |
0 | 0 | -2 | -2 | -0 | -2 | -9 | |
0 | 0 | 2 | 5 | -8 | -4 | 21 | |
Net Cash Flow | 0 | 0 | 2 | -2 | 4 | 3 | 5 |
Ratios
Figures in Rs. Crores
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | |
Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | |
Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | |
Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | |
Working Capital Days | 12 | 23 | 14 | 66 | 2 | 15 | |
ROCE % | 15% | 12% | 14% | 32% | 45% |
Documents
Announcements
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (LODR) Regulations, 2015 As On Period Ended March 31, 2024 21 May
- Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024. 21 May
- Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024. 21 May
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Half And Year Ended March 31, 2024 13 May
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Half And Financial Year Ended March 31, 2024 10 May
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions